NO20053720L - Antimikrobielt preparat for lokal anvendelse pa slimhinnemembraner og hud - Google Patents

Antimikrobielt preparat for lokal anvendelse pa slimhinnemembraner og hud

Info

Publication number
NO20053720L
NO20053720L NO20053720A NO20053720A NO20053720L NO 20053720 L NO20053720 L NO 20053720L NO 20053720 A NO20053720 A NO 20053720A NO 20053720 A NO20053720 A NO 20053720A NO 20053720 L NO20053720 L NO 20053720L
Authority
NO
Norway
Prior art keywords
composition
skin
mucous membranes
local application
preparation
Prior art date
Application number
NO20053720A
Other languages
English (en)
Other versions
NO335291B1 (no
Inventor
Jens Richard Pedersen
Torben Richard Pedersen
Original Assignee
Pedersen Medical As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK200301858A external-priority patent/DK200301858A/da
Application filed by Pedersen Medical As filed Critical Pedersen Medical As
Publication of NO20053720L publication Critical patent/NO20053720L/no
Publication of NO335291B1 publication Critical patent/NO335291B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SAMMENDRAG Oppfinnelsen angår et antimikrobielt preparat for lokal anvendelse på slimhinnemembraner og hud. Det antimikrobielle preparatet omfatter et system av lysozym og glykosylerte immunoglobuliner. De glykosylerte immunoglobulinene har affinitet mot gramnegative og grampositive bakterier og virus. Videre angår oppfinnelsen fremgangsmåten for å fremstille nevnte preparat så vel som anvendelse av preparatet for behandlingen og/eller forebyggingen av infeksjoner. Den foreliggende oppfinnelse angår videre et antimikrobielt preparat omfattende lysozym konjugert til et monosakkarid. Fremgangsmåten for å fremstille nevnte preparat så vel som anvendelsen av preparatet for behandlingen og/eller forebyggingen av infeksjoner er også beskrevet.
NO20053720A 2003-01-16 2005-08-02 Antimikrobielt preparat for lokal anvendelse på slimhinnemembraner og hud NO335291B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK200301858A DK200301858A (da) 2002-01-16 2003-01-16 Antimikrobielt præparat til lokal anvendelse på hud og slimhinder
PCT/DK2003/000940 WO2004060397A1 (en) 2003-01-02 2003-12-30 Antimicrobial composition for local use on mucosal membranes and skin

Publications (2)

Publication Number Publication Date
NO20053720L true NO20053720L (no) 2005-08-02
NO335291B1 NO335291B1 (no) 2014-11-03

Family

ID=32695534

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053720A NO335291B1 (no) 2003-01-16 2005-08-02 Antimikrobielt preparat for lokal anvendelse på slimhinnemembraner og hud

Country Status (10)

Country Link
US (1) US20060233781A1 (no)
EP (1) EP1587539B1 (no)
AT (1) ATE476199T1 (no)
AU (1) AU2003287936A1 (no)
CA (1) CA2551760A1 (no)
DE (1) DE60333679D1 (no)
DK (1) DK1587539T3 (no)
NO (1) NO335291B1 (no)
PL (1) PL378216A1 (no)
WO (1) WO2004060397A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102037885B1 (ko) 2010-11-23 2019-10-30 팬더릭스 인코포레이티드 광범위한, 미확인 또는 혼합된 임상적 적용에서 치료용 조성물들 및 방법들
US9913903B2 (en) * 2015-08-06 2018-03-13 Grifols Worldwide Operations Limited Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM
EP3479699A1 (en) * 2017-11-03 2019-05-08 Agriculture and Food Development Authority (TEAGASC) A composition and uses thereof
CN117717612A (zh) * 2023-12-19 2024-03-19 中山自然说生物科技有限公司 一种私密护理组合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
FR2573627B1 (fr) 1984-11-29 1986-12-26 Entremont Sa Procede pour la fabrication de produits laitiers au moyen d'anticorps
GB8906796D0 (en) 1989-03-23 1989-05-10 Medical Research Interntional Method of enhancing neutralising antibody activity in human or animal sera or in other body secretions
RU2070889C1 (ru) * 1993-03-30 1996-12-27 Институт пищевых веществ РАН Лизоцимполисахаридный конъюгат
JP4194758B2 (ja) 1998-04-02 2008-12-10 ザ プロクター アンド ギャンブル カンパニー 多ゾーン部材
JP2000270858A (ja) * 1999-03-26 2000-10-03 Taiyo Kagaku Co Ltd リゾチーム糖複合体
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms

Also Published As

Publication number Publication date
ATE476199T1 (de) 2010-08-15
CA2551760A1 (en) 2004-07-22
EP1587539B1 (en) 2010-08-04
DK1587539T3 (da) 2010-11-08
DE60333679D1 (de) 2010-09-16
US20060233781A1 (en) 2006-10-19
NO335291B1 (no) 2014-11-03
AU2003287936A1 (en) 2004-07-29
PL378216A1 (pl) 2006-03-20
EP1587539A1 (en) 2005-10-26
WO2004060397A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
WO1999052515A3 (de) Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
AU2003282358A1 (en) Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil
WO2002007742A3 (en) Bacteriophage having multiple host range
WO2003077828A3 (en) Novel florfenicol-type antibiotics
WO2003000200A3 (en) β-2'-OR 3'-HALONUCLEOSIDES
BRPI0413234A (pt) derivados de imidazola bicìclica contra flaviviridae
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
AU2002244710A1 (en) Chlamydia vaccine composition
WO2003099217A3 (en) Methods of treating bacterial infections and diseases associated therewith
WO2007053176A3 (en) Method of protecting against staphylococcal infection
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
NO20053720L (no) Antimikrobielt preparat for lokal anvendelse pa slimhinnemembraner og hud
WO2004098536A3 (en) Anti-viral activity of cathelicidin peptides
CL2004000710A1 (es) Composicion antimicrobiana y antiparasitaria formada por un antibiotico derivado del cloranfenicol o tianfenicol, un endectocida y por lo menos un vehiculo aceptable, y su uso para tratar enfermedades respiratorias y parasitarias de los bovinos.
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
EP1670490A4 (en) METHOD FOR INHIBITING BACTERIAL COLONIZATION
AU2002364964A1 (en) Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
WO2008105826A3 (en) Compositions compromising lysostaphin variants and methods of using the same
WO2004034961A3 (en) Antimicrobial agents and uses thereof
AU2002365083A1 (en) Composition and method to treat viral bacterial and parasitic infections and infestations
ATE364389T1 (de) Verfahren zur herstellung von extrakten aus pelargonium sidoides und/oder pelargonium reniforme
ATE420852T1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
WO2007050978A3 (en) Methods for the elimination of pathogens and other particulate agents
WO2003024996A3 (de) Antibakterielle makrozyklen
WO2005108563A3 (en) Peptidoglycan-hydrolyzing protein encoded by bacteriophage n4

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ACAPO AS, POSTBOKS 1880 NORDNES, 5817 BERGEN, NORG

MK1K Patent expired